1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. KINIKSA PHARMACEUTICALS LTD - ORDINARY SHARES - CLASS A
Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A XNAS: KNSA

Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A Live Stock Price Today, Share Analysis and Chart

Strong Performer, Getting Expensive
about

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical...

Read More
40.57 1.07 (2.71%)
Near 52W High of $42.05
276.8K
XNAS Volume

XNAS 11 Nov, 2025 4:30 PM (EST)

Watchlist

Portfolio

Alert
Durability score
High Financial Strength
61.1 / 100
Valuation Score
Mid Valuation
37.2 / 100
Momentum Score
Technically Bullish
73.3 / 100
Strong Performer, Getting Expensive These stocks are strong in quality and technical aspects but with medium valuation. Due to expensive valuation it is suggested that opportunity to be observed before buying. View Similar Embed DVM
Analyst Price Target
54
1Yr Price target upside is 33%
7 analysts

33

S

7

W

7

O

0

T

SWOT Analysis

Kiniksa Pharmaceuticals Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..